Navigation Links
Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
Date:2/26/2008

LAKE FOREST, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today announced a new national agreement with HealthTrust Purchasing Group, LP (HealthTrust). The multi-year contract will provide HealthTrust member organizations with access, on a non-exclusive basis, to Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals and drug-delivery products.

Through existing agreements, Hospira already provides pain-management infusion pumps to HealthTrust members, and infusion devices, I.V. solutions and equipment to members of Consorta -- a group purchasing organization (GPO) that joined HealthTrust in 2007.

"Hospira's products and services can help HealthTrust's members meet their goals -- from increasing patient safety to reducing costs and improving caregiver productivity," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "We look forward to developing strong relationships with HealthTrust's member healthcare institutions."

The new agreement includes Hospira's general-purpose medication infusion technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. The contract also provides access to Hospira's I.V. solutions and associated equipment portfolio, including the company's more environmentally preferable VisIV(R) container for I.V. solutions. This contract represents the first opportunity for Hospira to provide access to these products to HealthTrust members.

About HealthTrust

HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports over 3800 not-for-profit and for-profit facilities, which include acute care hospitals, ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027 Website: http://www.healthtrustpg.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 --

A Caution Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth under the heading "Item 1 Business -- Risk Factors" in Hospira's Annual Report on Form 10-K for the year ended Dec. 31, 2006, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
2. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
5. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
6. Thomson Healthcare Announces Enhancements to Order Sets Solution
7. Heska Announces Q4 and Annual 2007 Results
8. Acuo Technologies(R) Announces a Fully Integrated XDS-I Solution
9. The Quantum Group Announces Strategic Technology Alliance
10. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
11. China Bionanometer Industries Corporation Announces New Products for China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & Anti-aging ... Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading scientific experts, ...
(Date:12/5/2016)... Columbus, OH (PRWEB) , ... December 05, 2016 ... ... novel engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy ... usability in various healthcare settings. , Over the last 60 years, studies ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... While James Earl Jones is known ... for in a show called "Front Page". One of the forthcoming episodes examines mammogram ... rates have plummeted in large part due to early detection. Like any other disease, ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Entrepreneurial Company in the Dallas area” Tuesday evening at the 26th Annual SMU ... presented by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 2016   Pairnomix, LLC, a genetic research company ... by the White House, today announced that findings from its ... of candidate therapies for a patient with epileptic encephalopathy caused ... presented at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process ...
(Date:12/4/2016)... , Dec. 3, 2016  Findings from ... safety of CTL019, an investigational chimeric antigen receptor ... pediatric and young adult patients with B-cell acute ... an oral session at the 58th American Society ... 3, 4:00-5:30 p.m.). The global Phase II study ...
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical Laboratories, ... de la Compañía, el INSTI HIV Self Test , a los miembros ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
Breaking Medicine Technology: